Edwards Lifesciences Debt to Equity Ratio 2010-2024 | EW
Current and historical debt to equity ratio values for Edwards Lifesciences (EW) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Edwards Lifesciences debt/equity for the three months ending September 30, 2024 was 0.06.
| Edwards Lifesciences Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-09-30 | $3.36B | $9.61B | 0.35 |
| 2024-06-30 | $2.60B | $7.51B | 0.35 |
| 2024-03-31 | $2.55B | $7.19B | 0.36 |
| 2023-12-31 | $2.64B | $6.72B | 0.39 |
| 2023-09-30 | $2.64B | $6.73B | 0.39 |
| 2023-06-30 | $2.56B | $6.45B | 0.40 |
| 2023-03-31 | $2.59B | $6.06B | 0.43 |
| 2022-12-31 | $2.49B | $5.81B | 0.43 |
| 2022-09-30 | $2.42B | $6.22B | 0.39 |
| 2022-06-30 | $2.48B | $5.94B | 0.42 |
| 2022-03-31 | $2.58B | $5.85B | 0.44 |
| 2021-12-31 | $2.67B | $5.84B | 0.46 |
| 2021-09-30 | $2.62B | $5.54B | 0.47 |
| 2021-06-30 | $2.53B | $5.13B | 0.49 |
| 2021-03-31 | $2.56B | $4.66B | 0.55 |
| 2020-12-31 | $2.66B | $4.57B | 0.58 |
| 2020-09-30 | $2.59B | $4.21B | 0.62 |
| 2020-06-30 | $2.59B | $3.84B | 0.67 |
| 2020-03-31 | $2.18B | $3.90B | 0.56 |
| 2019-12-31 | $2.34B | $4.15B | 0.56 |
| 2019-09-30 | $2.15B | $3.82B | 0.56 |
| 2019-06-30 | $2.07B | $3.50B | 0.59 |
| 2019-03-31 | $2.02B | $3.45B | 0.59 |
| 2018-12-31 | $2.18B | $3.14B | 0.70 |
| 2018-09-30 | $2.60B | $3.36B | 0.77 |
| 2018-06-30 | $2.52B | $3.16B | 0.80 |
| 2018-03-31 | $2.58B | $3.25B | 0.80 |
| 2017-12-31 | $2.71B | $2.96B | 0.92 |
| 2017-09-30 | $2.33B | $3.16B | 0.74 |
| 2017-06-30 | $2.20B | $2.94B | 0.75 |
| 2017-03-31 | $2.04B | $2.74B | 0.74 |
| 2016-12-31 | $1.89B | $2.62B | 0.72 |
| 2016-09-30 | $1.65B | $2.69B | 0.61 |
| 2016-06-30 | $1.58B | $2.47B | 0.64 |
| 2016-03-31 | $1.56B | $2.30B | 0.68 |
| 2015-12-31 | $1.55B | $2.50B | 0.62 |
| 2015-09-30 | $1.46B | $2.42B | 0.60 |
| 2015-06-30 | $1.32B | $2.29B | 0.58 |
| 2015-03-31 | $1.28B | $2.21B | 0.58 |
| 2014-12-31 | $1.33B | $2.19B | 0.61 |
| 2014-09-30 | $1.31B | $2.04B | 0.64 |
| 2014-06-30 | $1.41B | $1.92B | 0.74 |
| 2014-03-31 | $1.31B | $1.34B | 0.98 |
| 2013-12-31 | $1.17B | $1.54B | 0.76 |
| 2013-09-30 | $1.09B | $1.44B | 0.76 |
| 2013-06-30 | $0.76B | $1.58B | 0.48 |
| 2013-03-31 | $0.71B | $1.59B | 0.44 |
| 2012-12-31 | $0.74B | $1.48B | 0.50 |
| 2012-09-30 | $0.66B | $1.54B | 0.43 |
| 2012-06-30 | $0.64B | $1.44B | 0.45 |
| 2012-03-31 | $0.61B | $1.39B | 0.44 |
| 2011-12-31 | $0.64B | $1.34B | 0.48 |
| 2011-09-30 | $0.63B | $1.36B | 0.46 |
| 2011-06-30 | $0.62B | $1.39B | 0.45 |
| 2011-03-31 | $0.57B | $1.36B | 0.42 |
| 2010-12-31 | $0.46B | $1.31B | 0.35 |
| 2010-09-30 | $0.49B | $1.23B | 0.40 |
| 2010-06-30 | $0.52B | $1.12B | 0.47 |
| 2010-03-31 | $0.45B | $1.15B | 0.39 |
| 2009-12-31 | $0.46B | $1.16B | 0.40 |
| 2009-09-30 | $0.51B | $1.09B | 0.47 |
| 2009-06-30 | $0.46B | $1.00B | 0.46 |
| 2009-03-31 | $0.42B | $0.94B | 0.44 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $38.832B | $6.005B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $212.628B | 25.94 |
| Intuitive Surgical (ISRG) | United States | $186.738B | 97.63 |
| Alcon (ALC) | Switzerland | $45.674B | 32.15 |
| IQVIA Holdings (IQV) | United States | $39.509B | 21.77 |
| IDEXX Laboratories (IDXX) | United States | $35.456B | 41.76 |
| DexCom (DXCM) | United States | $26.916B | 40.53 |
| Waters (WAT) | United States | $22.926B | 33.90 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.977B | 0.00 |
| STERIS (STE) | Ireland | $21.252B | 24.49 |
| Hologic (HOLX) | United States | $18.417B | 19.43 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.517B | 12.85 |
| Sysmex ADR (SSMXY) | Japan | $12.405B | 38.90 |
| Globus Medical (GMED) | United States | $11.099B | 28.27 |
| Teleflex (TFX) | United States | $9.197B | 14.67 |
| Penumbra (PEN) | United States | $8.945B | 87.62 |
| Masimo (MASI) | United States | $8.639B | 41.80 |
| Glaukos (GKOS) | United States | $7.682B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.022B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.514B | 25.59 |
| Inari Medical (NARI) | United States | $3.035B | 0.00 |
| TransMedics (TMDX) | United States | $2.870B | 90.96 |
| Veracyte (VCYT) | United States | $2.868B | 86.84 |
| LivaNova (LIVN) | United Kingdom | $2.823B | 16.30 |
| Nihon Kohden (NHNKY) | Japan | $2.488B | 18.90 |
| Elekta AB (EKTAY) | Sweden | $2.336B | 19.03 |
| Tandem Diabetes Care (TNDM) | United States | $2.188B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.968B | 10.29 |
| RxSight (RXST) | United States | $1.881B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.334B | 0.00 |
| Artivion (AORT) | United States | $1.214B | 80.50 |
| Pulse Biosciences (PLSE) | United States | $1.106B | 0.00 |
| OPKO Health (OPK) | United States | $1.011B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.939B | 15.96 |
| IRadimed (IRMD) | United States | $0.707B | 38.23 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.696B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.668B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.666B | 0.00 |
| SiBone (SIBN) | United States | $0.649B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.638B | 15.10 |
| Paragon 28 (FNA) | United States | $0.591B | 0.00 |
| AxoGen (AXGN) | United States | $0.582B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.492B | 0.00 |
| CVRx (CVRX) | United States | $0.377B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.370B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.366B | 19.81 |
| Delcath Systems (DCTH) | United States | $0.304B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.291B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.276B | 18.50 |
| Sight Sciences (SGHT) | United States | $0.235B | 0.00 |
| Inogen (INGN) | United States | $0.224B | 0.00 |
| NeuroPace (NPCE) | United States | $0.221B | 0.00 |
| Accuray (ARAY) | United States | $0.210B | 0.00 |
| Nevro (NVRO) | United States | $0.199B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.189B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.156B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.129B | 0.00 |
| 908 Devices (MASS) | United States | $0.126B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.114B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.107B | 15.95 |
| EDAP TMS S.A (EDAP) | France | $0.101B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.090B | 0.00 |
| LENSAR (LNSR) | United States | $0.080B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.079B | 0.00 |
| Hyperfine (HYPR) | United States | $0.070B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | Israel | $0.059B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.054B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.047B | 0.00 |
| Envoy Medical (COCH) | United States | $0.040B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Neuronetics (STIM) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.029B | 0.00 |
| Precision Optics (POCI) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.025B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.014B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |